Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABCD: Cilostazol + DAPT after Biolimus-Eluting Stent
NCT01192724Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Mar 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cilostazol in coronary artery disease (CAD) (2 arms), sponsored by Yonsei University. Primary endpoint: Device-oriented composite endpoint at 1 year. Started Mar 2010; status: completed.
02
Drugs
cilostazol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01192724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01192724.